The A1166C polymorphism of the AT1 receptor gene is associated with collagen type I synthesis and myocardial stiffness in hypertensives

Journal of Hypertension

Volumn 21, Issue 11, 2003, Pages 2085-2092

  Díez, Javier ^a,b   Laviades, Concepción ^c   Orbe, Josune ^a   Zalba, Guillermo ^a   López, Begoña ^a   González, Arantxa ^a   Mayor, Gaspar ^c   Páramo, José A ^a   Beloqui, Oscar ^b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

^c HOSPITAL SAN JORGE   (Spain)

Author keywords

Angiotensin; Extracellular matrix; Fibrosis; Hypertension; Receptors

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ATENOLOL; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; HYDROCHLOROTHIAZIDE; LOSARTAN; MARKER; NUCLEIC ACID BASE; PROCOLLAGEN C PROTEINASE; ADENINE; ANTIHYPERTENSIVE AGENT; CYTOSINE;

ADULT; AGED; ARTICLE; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DECELERATION; DISEASE ASSOCIATION; DNA POLYMORPHISM; DOPPLER ECHOCARDIOGRAPHY; DRUG RESPONSE; EXTRACELLULAR SPACE; FEMALE; GENOTYPE; HEART LEFT VENTRICLE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MITRAL VALVE; MYOCARDIAL DISEASE; MYOCARDIAL STIFFNESS; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; RADIOIMMUNOASSAY; RIGIDITY; ALLELE; BIOSYNTHESIS; ELASTICITY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; HEART; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

ADENINE; ADULT; AGED; ALLELES; ANTIHYPERTENSIVE AGENTS; ATENOLOL; COLLAGEN TYPE I; CYTOSINE; ELASTICITY; FEMALE; GENE FREQUENCY; GENOTYPE; HEART; HUMANS; HYPERTENSION; LOSARTAN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 1542270216     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200311000-00018     Document Type: Article

References (40)

1. Pfeffer JM, Pfeffer MA, Fishbein MC, Frohlich ED. Cardiac function and morphology with aging in the spontaneously hypertensive rat. Am J Physiol 1979; 6:H461-H468.
2. Panizo A, Pardo J, Hernández M, Galindo MF, Cenarruzabeitia E, Díez J. Quinapril decreases myocardial accumulation of extracellular matrix components in spontaneously hypertensive rats. Am J Hypertens 1995; 8: 815-822.
3. Brilla CG, Matsubara L, Weber KT. Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosis. Hypertension 1996; 28:269-275.
4. Schwartzkopff B, Motz W, Frenzel H, Vogt M, Knauer S, Strauer BE. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation 1993; 88: 993-1003.
5. Mundhenke M, Schwartzkopff B, Strauer BE. Structural analysis of arteriolar and myocardial remodelling in the subendocardial region of patients with hypertensive heart disease and hypertrophic cardiomyopathy. Virchows Arch 1997; 431:265-273.
6. Pearlman ES, Weber KT, Janicki JS, Pietra GG, Fishman AP. Muscle fiber orientation and connective tissue content in the hypertrophied human heart. Lab Invest 1982; 46:158-164.
7. Querejeta R, Varo N, López B, Larman M, Artiñano E, Etayo JC, et al. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. Circulation 2000; 101:1729-1735.
8. Weber KT. Cardiac interstitium. In: Poole-Wilson PA, Colucci WS, Massie BM, Chatterjee K, Coats AJS (editors): Heart failure: scientific principles and clinical practice. New York: Churchill Livingstone; 1997, pp. 13-31.
9. Díez J, Querejeta R, López B, González A, Larman M, Martínez Ubago JL. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 2002; 105:2512-2517.
10. Weber KT, Eghbali M. Collagen matrix synthesis and degradation in the development and regression of left ventricular hypertrophy. Cardiovasc Rev Rep 1991; 12:61-69.
11. González A, López B, Querejeta R, Díez J. Regulation of myocardial fibrillar collagen by angiotensin II. A role in hypertensive heart disease? J Mol Cell Cardiol 2002; 34:1 585-1593.
12. López B, Querejeta R, Varo N, González A, Larman M, Martínez Ubago JL, et al. Usefulness of serum carboxy-terminal propeptide of procollagen type I to assess the cardioreparative ability of antihypertensive treatment in hypertensive patients. Circulation 2001; 104:286-291.
13. Bonnardeaux A, Davies E, Jeunemaitre X, Féry I, Charru A, Clauser E, et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994; 24:63-69.
14. Kainulainen K, Perola M, Terwilliger J, Kaprio J, Koskenvuo M, Syvänen AC, et al. Evidence for involvement of the type 1 angiotensin II receptor locus in essential hypertension. Hypertension 1999; 33:844-849.
15. Tiret L, Blanc H, Ruidavets JB, Arveiler D, Luc G, Jeunemaitre X, et al. Gene polymorphisms of the renin-angiotensin system in relation to hypertension and parenteral history of myocardial infarction and stroke: The PEGASE study. Projet d'Etude des Genes de l'Hypertension Arterielle Severe a Moderée Essentielle. J Hypertens 1998; 16:37-44.
16. Berge KE, Berg K. Polymorphisms at the angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) loci and normal blood pressure. Clin Genet 1998; 53:214-219.
17. Liyou N, Davis D, James K, Simons L, Friedlander Y, Simons J, et al. The A1166C mutation in the angiotensin II type I receptor and hypertension in the elderly. Clin Exp Pharmacol Physiol 1999; 26:525-526.
18. Wang WY, Zee RY, Morris BJ. Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension. Clin Genet 1997; 51:31-34.
19. Benethos A, Gautier S, Ricard S, Topouchian J, Asmar R, Poirier O, et al. Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation 1996; 94:698-703.
20. 1166A/C gene polymorphisms and increase in aortic stiffness with age in hypertensive subjects. J Hypertens 2001; 19:407-413.
21. Benetos A, Cambien F, Gautier S, Ricard S, Safar M, Laurent S, et al. Influence of the angiotensin II type 1 receptor gene polymorphism on the effects of perindopril and nitrendipine on arterial stiffness in hypertensive individuals. Hypertension 1996; 28:1081-1084.
22. López B, González A, Varo N, Laviades C, Querejeta R, Díez J. Biochemical assessment of myocardial fibrosis in hypertensive heart disease. Hypertension 2001; 38:1222-1226.
23. Guidelines Subcommittee. 1999 World Health Organization-international Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17:151-183.
24. Díez J, Laviades C, Mayor G, Gil MJ, Monreal I. Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations. Circulation 1995; 91:1450-1456.
25. Laviades C, Varo N, Fernández J, Mayor G, Gil MJ, Monreal I, et al. Abnormalities of the extracellular degradation of collagen type I in essential hypertension. Circulation 1998; 98:535-540.
26. Appleton CP, Hatle L, Popp RL. Relation of transmitral flow velocity patterns to left ventricular dysfunction: new insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol 1988; 12:426-440.
27. García MJ, Firstenberg MS, Greenberg NL, Smedirea N, Rodriguez L, Prior D, et al. Estimation of left ventricular operating stiffness from Doppler early filling deceleration time in humans. Am J Physiol 2001; 280:H554-H561.
28. Quinones MA, Pickering E, Alexander JK. Percentage of shortening of the echocardiographic left ventricular dimension: its use in determining ejection fraction and stroke volume. Chest 1987; 74:59-65.
29. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19:1550-1558.
30. García MJ, Thomas JD, Klein AL. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 1998; 32: 865-875.
31. Hingorami AD, Brown MJ. A simple molecular assay for the C1166 variant of the angiotensin II type 1 receptor gene. Biochem Biophys Res Commun 1995; 213:725-729.
32. Kurland L, Melhus H, Karlsson J, Kahan T, Malmqvist K, Ohman KP, et al. Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients. J Hypertens 2001; 19:1783-1787.
33. Kurland L, Melhus H, Karlsson J, Kahan T, Malmqvist K, Ohman P, et al. Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish lrbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial. J Hypertens 2002; 20: 657-663.
34. 1166C polymorphism in essential hypertensives on a high sodium diet. Hypertension 2000; 36:411-416.
35. van Geel PP, Pinto YM, Voors AA, Buikema H, Oosterga M, Crinjs HJ, et al. Angiotensin II type I receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries. Hypertension 2000; 35:717-721.
36. Miyahara M, Nijeha FK, Prockop DJ. Formation of collagen fibrils in vitro by cleavage of procollagen with procollagen proteinases. J Biol Chem 1982; 57:8442-8448.
37. López B, González A, Querejeta R, Larman M, Martínez Ubago JL, Díez J. Biochemical monitoring of myocardial fibrosis in hypertensive patients with heart failure. Am J Hypertens 2003; 16:15A.
38. Risteli J, Elomaa I, Niemi S, Risteli L. Radioimmunoassay for the pyridoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 1993; 39:635-640.
39. Laurent GJ. Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass. Am J Physiol 1987; 251:C1-C9.
40. Díez J, López B, González A, Querejeta R. Clinical aspects of hypertensive myocardial fibrosis. Curr Opin Cardiol 2001; 16:328-335.